Skip to main content
. 2020 Oct 29;22:258. doi: 10.1186/s13075-020-02326-5

Fig. 3.

Fig. 3

Measures of treatment efficacy over time. Rates of Juvenile Disease Activity Score (JADAS)10-minimal disease activity (JADAS10 ≤ 3.8) and JADAS10-remission (JADAS10 ≤ 1) and rates of patients reaching inactive disease according to Wallace et al. [13] upon etanercept treatment